Retinoic acid induces persistent, RARα-mediated anti-proliferative responses in Epstein-Barr virus-immortalized B lymphoblasts carrying an activated c-myc oncogene but not in Burkitt's lymphoma cell lines

International Journal of Cancer

Volumn 89, Issue 2, 2000, Pages 375-384

  Cariati, Roberta ^a   Zancai, Paola ^a   Quaia, Michele ^a   Cutrona, Giovanna ^b   Giannini, Franca ^a   Rizzo, Silvana ^a   Boiocchi, Mauro ^a   Dolcetti, Riccardo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; ANTINEOPLASTIC AGENT; MYC PROTEIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; BURKITT LYMPHOMA; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG EFFECT; EPSTEIN BARR VIRUS; GROWTH INHIBITION; LYMPHOBLAST; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; RECEPTOR UPREGULATION; TUMOR GROWTH; B LYMPHOCYTE; CELL CULTURE; CELL DIVISION; CELL LINE; GENE TRANSFER; GENETICS; HUMAN; METABOLISM; ONCOGENE MYC; PATHOLOGY; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION;

ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; GENE TRANSFER TECHNIQUES; GENES, MYC; HERPESVIRUS 4, HUMAN; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034185986     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000501)86:3<375::aid-ijc12>3.0.co;2-z     Document Type: Article

References (30)

1. APFEL, C., BAUER, F., CRETTAZ, M., FORNI, L., KAMBER, M., KAUFMANN, F., LE MOTTE, P., PIRSON, W. and KLAUS, M., A retinoid acid receptor antagonist selectively counteracts retinoic acid effects. Proc. nat. Acad. Sci. (Wash.), 89, 7129-7133 (1992).
2. BRIMMELL, M., MENDIOLA, R., MANGION, J. and PACKHAM, G., BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene, 16, 1803-1812 (1998).
3. CASTLEBERRY, R.P., EMANUEL, P.D., ZUCKERMAN, K.S., COHN, S., STRAUSS, L., BYRD, R.L., HOMANS, A., CHAFFEE, S., NITSCHKE, R. and GUALTIERI, R.J., A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N. Engl J. Med., 331, 1680-1684 (1994).
4. CHAMBON, P., A decade of molecular biology of retinoic acid receptors. FASEB J., 10, 940-954 (1996).
5. CHEN, J.-Y., CLIFFORD, J., ZUSI, C., STARRETT, J., TORTOLANI, D., OSTROWSKI, J., RCZECK, P.R., CHAMBON, P. and GRONEMEYER, H., Two distinct actions of retinoid-receptor ligands. Nature (Lond.), 382, 819-822 (1996).
6. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
7. CUTRONA, G., ULIVI, M., FAIS, F., RONCELLA, S. and FERRARINI, M., Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J. exp. Med., 181, 699-711 (1995).
8. DELECLUSE, H.J., ROUAULT, J.P., PFRENCH, M., DUREAU, G., MAGAUD, J.P. and BERGER, F., Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours. Brit. J. Haematol., 89, 90-97 (1995).
9. DE VITA, S., DOLCETTI, R., FERRACCIOLI, G.F., PIVETTA, B., DE RE, V., GLOGHINI, A., D'AGOSTO, A., BARTOLI, E., CARBONE, A. and BOIOCCHI, M., Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome. J. Rheumatol., 22, 1674-1680 (1995).
10. + T cells in vitro. Int. J. Cancer, 68, 810-816 (1996).
11. FARRELL, P.J., ALLAN, G.J., SHANAHAN, F., VOUSDEN, K.H. and CROOK, T., p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J., 10, 2879-2887 (1991).
12. FENAUX, P., CHOMIENNE, C. and DEGOS, L., Acute promyelocytic leukemia: biology and treatment. Semin. Oncol., 24, 92-102 (1997).
13. FRENCH, L.E., RAMELET, A.A. and SAURAT, J.-H., Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin. Lancet, 344, 686-687 (1994).
14. GAIDANO, G., BALLERINI, P., GONG, J.Z., INGHIRAMI, G., NERI, A., NEWCOMB, E.W., MAGRATH, I.T., KNOWLES, D.M. and DALLA-FAVERA, R., p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. nat. Acad. Sci. (Wash.), 88, 5413-5417 (1991).
15. GIANNINI, F., MAESTRO R., VUKOSAVLJEVIC, T., POMPONI, F. and BOIOCCHI, M., All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int. J. Cancer, 70, 194-200 (1997).
16. KALEMKERIAN, G.P., JASTI, R.K., CELANO, P., NELKIN, B.D. and MABRY, M., All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Cell Growth Differentiation, 5, 55-60 (1994).
17. LEHMANN, J.M., JONG, L., FANJUL, A., CAMERON, J.F., LU, X.P., HAEFNER, P., DAWSON, M.I. and PFAHL, M., Retinoids selective for retinoid X receptor response pathways. Science, 258, 1944-1946 (1992).
18. LIPPMAN, S.M. and DAVIES, P.J., Retinoids, neoplasia and differentiation therapy. Cancer Chemother. biol. Response Modif., 17, 349-362 (1997).
19. LOCKER, J. and NALESNIK, M., Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Amer. J. Pathol., 135, 977-987 (1989).
20. LOMBARDI, L., NEWCOMB, E.W. and DALLA-FAVERA, R., Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell, 49, 161-170 (1987).
21. LØMO, J., SMELAND, E.B., ULVEN, S., NATARAJAN, V., BLOMHOFF, R., GANDHI, U., DAWSON, M.I. and BLOMHOFF, H.K., RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J. cell. Physiol., 175, 68-77 (1998).
22. LOTAN, R., Retinoids in cancer chemoprevention. FASEB J., 10, 1031-1039 (1996).
23. MÜLLER, D., BOUCHARD, C., RUDOLPH, B., STEINER, P., STUCKMANN, I., SAFFRICH, R., ANSORGE, W., HUTTNER, W. and EILERS, M., Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576 (1997).
24. PACKHAM, G. and CLEVELAND, J.L., c-myc and apoptosis. Biochim. Biophys. Acta, 1242, 11-28 (1995).
25. PFAHL, M., Vertebrate receptors: molecular biology, dimerization and response elements. Semin. Cell. Biol., 5, 95-103 (1994).
26. POMPONI, F., CARIATI, R., ZANCAI, P., DE PAOLI, P., RIZZO, S., TEDESCHI, R.M., PIVETTA, B., DE VITA, S., BOIOCCHI, M. and DOLCETTI, R., Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood, 88, 3147-3159 (1996).
27. PONTE, P., GUNNING, P., BLAU, H. and KEDES, L., Human actin genes are single copy for alfa skeletal and alfa-cardiac actin but multicopy for beta-and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol. cell. Biol., 3, 1783-1791 (1983).
28. SEEWALDT, V.L., JOHNSON, B.S., PARKER, M.B., COLLINS, S.J. and SWISSHELM, K., Expression of retinoic acid receptor β-mediated retinoid-induced growth arrest and apoptosis in breast cancer cells. Cell. Growth Differentiation, 6, 1077-1088 (1995).
29. WESTIN, E.H., WONG-STAAL, F., GELMANN, E.P., DALLA-FAVERA, R., PAPAS, T.S., LAUTENBERGER, J.A., EVA, A., REDY, E.P., TRONICK, S.R., AARONSON, S.A. and GALLO, R.C., Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc. nat. Acad. Sci. (Wash.), 79, 2490-2494 (1982).
30. kip-1 up-regulation is a relevant early event. Oncogene, 17, 1827-1836 (1998).